Daniel Santamaria del Angel

Dr. Daniel Santamaria del Angel

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
DADaniel Santamaria del Angel
Daniel Santamaria del Angel
NLNorma Angélica Labra-Ruíz
Norma Angélica Labra-Ruíz
MGMercedes Edna García-Cruz
Mercedes Edna García-Cruz
DCDavid Calderón-Guzmán
David Calderón-Guzmán
AVArmando Valenzuela-Peraza
Armando Valenzuela-Peraza
HOHugo Juarez Olguin
Hugo Juarez Olguin

31 May 2024 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
DGDavid Calderón Guzmán
David Calderón Guzmán
HOHugo Juarez Olguin
Hugo Juarez Olguin
NBNorma Osnaya Brizuela
Norma Osnaya Brizuela
MHMaribel Ortíz Herrera
Maribel Ortíz Herrera
FJFrancisca Trujillo Jimenez
Francisca Trujillo Jimenez
GMGerardo Barragán Mejía
Gerardo Barragán Mejía

30 October 2010 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
DGDavid Calderón Guzmán
David Calderón Guzmán
EGErnestina Hernández García
Ernestina Hernández García
NBNorma Osnaya Brizuela
Norma Osnaya Brizuela
FJFrancisca Trujillo Jiménez
Francisca Trujillo Jiménez
GBGerardo Barragán-Mejía
Gerardo Barragán-Mejía
LCLiliana Carmona-Aparicio
Liliana Carmona-Aparicio

Verified
Journal Article
Open access
PDF file
DGDavid CALDERON Guzman
David CALDERON Guzman
NBNorma Osnaya Brizuela
Norma Osnaya Brizuela
MHMaribel Ortíz Herrera
Maribel Ortíz Herrera
APArmando Valenzuela Peraza
Armando Valenzuela Peraza
NRNorma Labra Ruíz
Norma Labra Ruíz
GMGerardo Barragán Mejía
Gerardo Barragán Mejía
Neurotoxicity is a major obstacle in the effectiveness of Cisplatin in cancer chemotherapy. In this process, oxidative stress and inflammation are considered to be the main mechanisms involved in brain and lung toxicity. The aim of the present work was to study the influence of the amount of protein on some oxidative parameters in the brain and lungs of rats treated with Cisplatin (CP) and N-Acetylcysteine (NAC) as neuroprotectors. Four groups of Wistar rats, each containing six animals, were fed with a protein diet at 7% for 15 days. Thereafter, the groups were given either a unique dose of CP® 5 mg/kg or NAC® 5 mg/kg as follows: group 1 (control), NaCl 0.9% vehicle; group 2, CP; group 3, NAC; and group 4, NAC + CP. The animals were sacrificed immediately after the treatments. Blood samples were collected upon sacrifice and used to measure blood triglycerides and glucose. The brain and lungs of each animal were obtained and used to assay lipid peroxidation (TBARS), glutathione (GSH), serotonin metabolite (5-HIAA), catalase, and the activity of Ca+2, and Mg+2 ATPase using validated methods. TBARS, H2O2, and GSH were found to be significantly decreased in the cortex and cerebellum/medulla oblongata of the groups treated with CP and NAC. The total ATPase showed a significant increase in the lung and cerebellum/medulla oblongata, while 5-HIAA showed the same tendency in the cortex of the same group of animals. The increase in 5-HIAA and ATPase during NAC and CP administration resulted in brain protection. This effect could be even more powerful when membrane fluidity is increased, thus proving the efficacy of combined NAC and CP drug therapy, which appears to be a promising strategy for future chemotherapy in malnourished patients.

1 May 2003 in Nutritional Neuroscience
Verified
Journal Article
Closed access
DGDavid Calderón Guzmán
David Calderón Guzmán
NRNorma Labra Ruiz
Norma Labra Ruiz
GBGerardo Barragán-Mejía
Gerardo Barragán-Mejía
EGErnestina Hernández García
Ernestina Hernández García
IVIvonne R. Espitia Vázquez
Ivonne R. Espitia Vázquez
HOHugo Juarez Olguin
Hugo Juarez Olguin
Objective: To evaluate the antioxidant effect of selenium on Na+, K+-ATPase in rat brain in the presence of nitric oxide. Methods: Male Wistar rats (70 g) were treated as follows: group 1 received 1 μg of i.p. sodium nitroprusside per kg (SNP), group 2 received 5 μg sodium selenite during 20 days, group 3 received sodium selenite 5 μg+SNP 1 μg and the control group received vehicle 50 μl (0.9% NaCl), same period and route. At the end of treatment, animals were sacrificed and their brain dissected into cortex, hemispheres, cerebellum and brain stem in order to determine lipid peroxidation (TBARS), Na+, K+ ATPase and total ATPase in each section. Blood hemoglobin concentration (Hb) and prostate weight were also assessed. Results: A significant increase of Hb in blood and of proteins in cortex and hemisphere was detected, but TBARS values fell due to the effect of sodium selenite in all examined regions, except for cerebellum. ATPase activity declined in all groups and regions with and without NTP. We conclude that diet supplementary selenium to inhibit NO generation can be a useful treatment in chronic inflammatory diseases.

16 July 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DGDavid CALDERON Guzman
David CALDERON Guzman
NBNorma Osnaya Brizuela
Norma Osnaya Brizuela
MHMaribel Ortiz Herrera
Maribel Ortiz Herrera
HOHugo Juarez Olguin
Hugo Juarez Olguin
APArmando Valenzuela Peraza
Armando Valenzuela Peraza
DADaniel Santamaria del Angel
Daniel Santamaria del Angel
This study tested the hypothesis that flavonoids (diosmine, hesperidin and rutin®) play a protective role in the brain and duodenum against 3-Nitropropionic acid (3-NPA) free radical induced inflammation. This was achieved by measuring the levels of GABA, 5-HIAA, dopamine and some inflammation and oxidative stress markers. Male young Wistar rats (weight 60g) received Salmonella thyphimurium ATCC14028 1x10 6 CFU/g every week, for two consecutive weeks, plus the following treatments: group A, 0.9% NaCl (Control); group B, diosmine (300 mg) + hesperidin (33.3g) + rutin (150 mg/kg); group C, 3-NPA; group D, 3-NPA + mix of flavonoids with 1 ml of rutin® per rat. 3-NPA administration was at 24 mg/kgW by intraperitoneal route and the flavonoids were orally administered at every 48 hours for 15 days. At the moment of euthanasia, the blood was obtained to assess Interleukine-6, glucose, triglycerides and hemoglobin levels. Brain and duodenum were obtained to measure GABA, dopamine, 5-HIAA, lipoperoxidation, reduced glutathione (GSH), total ATPase concentrations and catalase activity using validated methods. The brains, stomach and duodenum were dissected for histological analysis. In group A, there is a decrease in interleukine-6 levels (p = 0.009). In the cortex region of animals in group C, dopamine experienced a significant decrease (p = 0.012). GABA increased (p = 0.001) in cerebellum regions of animals in the groups A, B and C. ATPase activity increased (p = 0.013) in cerebellum regions in animals of groups C and D. Lipoperoxidation diminished (p = 0.043) in cerebellum region of group D. Catalase activity diminished (p = 0.043) in Cortex region of animals in groups B and D, and (p = 0.002) in cerebellum region of animals in groups A and B. Besides, histological changes revealed marked lesions of neuronal cells in experimental animals treated with nitro propionic acid. The protective role of flavonoids and rutin compounds on inhibition of the inflammatory response and correction of the fundamental oxidant/antioxidant imbalance in animals suffering from Huntington diseases are important vistas for further research.